Application 078305
- Type
- ANDA
- Sponsor
- FOUGERA PHARMS
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | CALCIPOTRIENE | CALCIPOTRIENE | SOLUTION;TOPICAL | 0.005% | No | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A078305-001 | CALCIPOTRIENE | CALCIPOTRIENE | 0.005% | SOLUTION / TOPICAL | AT | 2008-05-06 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| A078305-001 | AT |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-01 22:54:32 | 2026-06 | A078305-001 | CALCIPOTRIENE | 0.005% | SOLUTION / TOPICAL | AT | 2008-05-06 | a50c72e98297… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-08-01 22:54:32 | 2026-06 | A078305-001 | AT | 1 | a50c72e98297… |
openFDA label cross-check#
Cross-check layer: openFDA label JSON enriches search and identifies hydration gaps. The DailyMed Structured Product Label remains the canonical label presentation on FDA.report. Every label matching the complete exact-identifier union is deduplicated and paginated below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Calcipotriene | CALCIPOTRIENE | Sun Pharmaceutical Industries, Inc. | 277d843a-0ea9-429d-813d-49ed72dafb64 | 2026-07-14 | Adverse reactions | Calcipotriene CALCIPOTRIENE |
| Calcitrene | CALCIPOTRIENE | Sun Pharmaceutical Industries, Inc. | 94d4f46a-f254-4fe2-b4bd-7a533d6324fe | 2026-07-14 | Adverse reactions | CALCIPOTRIENE |
| Pellix | CALCIPOTRIENE | Perfero Pharma, Inc. | 492ea9cf-0117-4d84-a964-9c0121706ed3 | 2026-05-04 | Warnings, Adverse reactions | CALCIPOTRIENE |
| Calcipotriene | CALCIPOTRIENE | Glenmark Pharmaceuticals Inc., USA | 1bc020e0-b5ae-4cda-aa5b-87fa0452a6bc | 2026-01-23 | Warnings, Adverse reactions | Calcipotriene CALCIPOTRIENE |
| calcipotriene | CALCIPOTRIENE | Glenmark Pharmaceuticals Inc.,USA | 7ec750f6-26ea-46bc-aa7b-174fd25253a2 | 2025-10-27 | Warnings, Adverse reactions | calcipotriene CALCIPOTRIENE |
| calcipotriene | CALCIPOTRIENE | Northstar Rx LLC | a882ef4f-603e-4421-97ae-2c78822c767a | 2024-06-24 | Warnings, Adverse reactions | calcipotriene CALCIPOTRIENE |
| calcipotriene | CALCIPOTRIENE | Mayne Pharma | 26756ac7-a80c-49db-97bb-351f76ad8a71 | 2024-05-09 | Warnings, Adverse reactions | calcipotriene CALCIPOTRIENE |
| SORILUX | CALCIPOTRIENE | Mayne Pharma | 51f208d0-7b3f-44cc-8bed-92fa3d2e7bbe | 2024-05-09 | Warnings, Adverse reactions | CALCIPOTRIENE |
| Calcipotriene | CALCIPOTRIENE | Prasco Laboratories | 377eafda-737c-4ba2-9ec5-61209b8814ed | 2022-12-12 | Warnings, Adverse reactions | Calcipotriene CALCIPOTRIENE |
| Calcipotriene | CALCIPOTRIENE | Cosette Pharmaceuticals, Inc. | 21378c25-5622-8bf7-1a8c-b05940a846a0 | 2022-11-15 | Warnings, Adverse reactions | Calcipotriene CALCIPOTRIENE |
| calcipotriene | CALCIPOTRIENE | Prasco Laboratories | fe7cd92a-f066-4c4a-80c8-e3f929ad4181 | 2020-08-07 | Warnings, Adverse reactions | calcipotriene CALCIPOTRIENE |
NDC Listings For This Application#
Documents#
| Document | Submission type | Date |
|---|---|---|
| 9140 | ORIG | 2008-05-08 |